LEIPZIG, GERMANY — With age comes illness: Cancer, cardiovascular and neurodegenerative diseases, increased infections, and autoimmune diseases such as rheumatism become more common. This is because […]
The European Commission has granted marketing authorization for Fresenius Kabi’s tocilizumab biosimilar, Tyenne. This is the first tocilizumab biosimilar granted marketing authorization in Europe, according to […]
TOPLINE: The incidence of extraarticular manifestations of rheumatoid arthritis (ExRA) has declined over time, but the manifestations’ association with increased mortality risk has not changed. METHODOLOGY: […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.